Publikationen von Hellerbrand, C.

Kurz, B., Arndt, S. , Unger, P., Ivanova, I. , Berneburg, Mark , Hellerbrand, C. und Karrer, Sigrid (2022) Association of polymorphous light eruption with NOD ‐2 and TLR ‐5 gene polymorphisms. Journal of the European Academy of Dermatology and Venereology 36 (11), S. 2172-2180.

Dietrich, P., Kuphal, S., Spruss, T., Hellerbrand, C. und Bosserhoff, A. K. (2018) Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition. Oncogene 37 (7), S. 897-911. Volltext nicht vorhanden.

Dietrich, P., Moleda, Lukas, Kees, Frieder K., Müller, M., Straub, R. H., Hellerbrand, C. und Wiest, R. (2013) Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y. Journal of hepatology 58 (2), S. 254-261. Volltext nicht vorhanden.

Wrede, C. E., Buettner, R., Bollheimer, L. C., Schölmerich, J., Palitzsch, K.-D. und Hellerbrand, C. (2006) Association between serum ferritin and the insulin resistance syndrome in a representative population. European journal of endocrinology / European Federation of Endocrine Societies 154 (2), S. 333-340. Zugang zum Volltext eingeschränkt.